O’Sullivan CoyneGWoodringTSLeeCRChenAPKongHH.Hidradenitis suppurativa-like lesions associated with pharmacologic inhibition of gamma-secretase. J Invest Dermatol. 2018;138(4):979-981. doi:10.1016/j.jid.2017.09.051
2.
FrantzTCKirwinDBraheC.Hidradenitis secondary to nirogacestat, a recently approved desmoid tumor medication. JAAD Case Rep. 2024;57:1-2. doi:10.1016/j.jdcr.2024.12.022
3.
GutierrezYDeClerckBHsiaoJLLeeKH.New onset hidradenitis suppurativa and eruptive milia associated with gamma secretase inhibitor therapy in a patient with desmoid tumor: a case report. JAAD Case Rep. 2025;63:81-83. doi:10.1016/j.jdcr.2025.05.042
4.
Hansen TaiBAHillKTParvathaneniAIslamZCohenSR.Androgenic hidradenitis suppurativa onset linked to gamma secretase inhibitor. JAAD Case Rep. 2025;67:202-204. doi:10.1016/j.jdcr.2025.10.038
5.
WendlandZTeerlinkCCPridgenKM, et al. A genome-wide association study of hidradenitis suppurativa from the VA’s Million Veteran Program. medRxiv (Preprint). 2025:2025:25330121. doi:10.1101/2025.06.23.25330121
